52N-12947-72842 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-08
Dose 1 — Pfizer-BioNTech
2021-05-05
Dose 2 — Pfizer-BioNTech
2021-06-21
Registered in v-safe
2021-06-21
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-08-04
Survey response — 3 months, dose 2
MedDRA: Menstruation irregular, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: cold symptoms but negative covid and strep tests. also irregular periods.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-04
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-09
Call 1 — Could Not Reach Participant
2021-08-12
Call 2 — Could Not Reach Participant

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-08	Pfizer-BioNTech	No
2	2021-05-05	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-08-04	Unsuccessful

Free text

Release 9 — 3 months, dose 2

2021-08-04

Symptoms: cold symptoms but negative covid and strep tests. also irregular periods.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Menstruation irregular	✓	·	✓
SD	Nasopharyngitis	✓	·	✓
SD	SARS-CoV-2 test negative	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release